Decision aids and prostate cancer: how useful are they?

Your sitemaster has long had concerns about the real value of decision aids in helping men to think about and come to conclusions about controversial issues in the diagnosis and management of prostate cancer. … READ MORE …

ASCO endorses AUA/ASTRO/SUO guidelines on treatment of localized prostate cancer

We are delighted to note that the American Society of Clinical Oncology (ASCO) has now endorsed 66 of the 68 guidelines issued in April 2017 on the treatment of localized prostate cancer by a joint working group from the American Uriological Association (AUA), the American Society of Radiation Oncology (ASTRO), and the Society for Urologic Oncology (SUO). … READ MORE …

How can shared decision-making work well if we aren’t starting from the same point?

Now here is a very interesting set of data from (admittedly) a small pilot study by a group of Italian researchers. … READ MORE …

Why “patient-reported outcomes” are important

As regular readers will be aware, your sitemaster is a tad obsessed with the quality of “care” that patients receive from their healthcare providers (as opposed to “just” the quality of their diagnosis and treatment). … READ MORE …

Race and decision-making in prostate cancer management

An article in Oncology Nurse Advisor notes that “Black and white men prioritize certain treatment-related factors differently when considering prostate cancer treatment options.” … READ MORE …

Don’t underestimate George Berger!

Don’t underestimate patients” is a new blog post on The Health Care Blog web site by George Berger, who is a regular commentator on the posts on this web site. … READ MORE …

Patient follow-up and care after first-line treatment for prostate cancer

Some of the most interesting data on the management of prostate cancer seem to be coming out of Australia in recent years — and the newly reported data from the ProCare trial is a case in point. … READ MORE …